文献速递炎症性肠病

临床疾病活动度与青少年及青年炎症性肠病患者的焦虑和抑郁症状相关

Clinical disease activity is associated with anxiety and depressive symptoms in adolescents and young adults with inflammatory bowel disease.
PubMed 文献 · Aliment Pharmacol Ther · 2018-06-13

这项前瞻性研究在374例10-25岁荷兰炎症性肠病患者中,用年龄特异性问卷筛查焦虑、抑郁和生活质量,对评分升高者进行诊断性访谈。结果显示轻度焦虑/抑郁症状占35.2%、严重症状占12.4%,活动性疾病显著预测抑郁症状(OR 4.6)。作者建议对年轻炎症性肠病患者进行心理筛查。

要点

  • 轻度焦虑/抑郁症状见于35.2%的患者,严重症状见于12.4%。
  • 活动性疾病显著预测抑郁症状(OR 4.6,95%CI 2.4-8.8,P<0.001)。
  • 女性、活动性疾病和较短病程显著预测焦虑和/或抑郁症状。

核心结论

  • 考虑到焦虑和抑郁症状的高患病率,建议对年轻炎症性肠病患者进行心理筛查,筛查有助于早期识别和心理治疗;女性患者和活动性疾病患者最易感。

研究设计与样本

  • 前瞻性研究,纳入374例10-25岁荷兰炎症性肠病患者,使用年龄特异性经验证问卷筛查焦虑、抑郁和生活质量,对焦虑和/或抑郁症状评分升高的患者进行诊断性访谈以评估精神障碍,从病历中获取人口学和临床特征,采用多元逻辑回归分析识别焦虑和/或抑郁的危险因素。

主要发现

  • 患者平均年龄18.9岁,男性44.1%,克罗恩病60.4%;疾病处于缓解期者75.4%,轻度、中度和重度临床疾病活动度分别占19.8%、2.7%和2.1%。
  • 轻度焦虑/抑郁症状见于35.2%的患者,严重症状见于12.4%。
  • 焦虑症状升高者占28.3%,抑郁症状升高者占2.9%,两者均升高者占15.8%,在青少年(10-17岁)和青年(18-25岁)之间无差异。
  • 活动性疾病显著预测抑郁症状(OR 4.6,95%CI 2.4-8.8,P<0.001)。
  • 女性(OR 1.7,95%CI 1.1-2.7)、活动性疾病(OR 1.9,95%CI 1.1-3.2)和较短病程(OR 1.3,95%CI 0.6-1.0)(均P<0.025)显著预测焦虑和/或抑郁症状。

临床怎么用

  • 作者建议对年轻炎症性肠病患者进行心理筛查,以促进早期识别和心理治疗,并指出女性患者和活动性疾病患者最易感。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Youths with inflammatory bowel disease (IBD) are at risk for developing anxiety and depressive symptoms with a reported 20%-50% prevalence rate. AIMS: This prospective study aimed to: (1) describe the prevalence and severity of anxiety and depressive symptoms in a large Dutch cohort of young IBD patients, and (2) identify demographic and clinical risk factors for anxiety and depression. METHODS: IBD patients (n = 374; 10-25 years) were screened for anxiety, depression and quality of life using validated age-specific questionnaires. Patients with elevated scores for anxiety and/or depressive symptoms received a diagnostic interview assessing psychiatric disorders. Demographic and clinical characteristics were retrieved from medical charts. Multiple logistic regression analysis was performed to identify risk factors for anxiety and/or depression. RESULTS: Patients (mean age 18.9 years, 44.1% male, Crohn's disease 60.4%) had disease in remission (75.4%), or mild, moderate and severe clinical disease activity in, respectively, 19.8%, 2.7% and 2.1%. Mild anxiety/depressive symptoms were present in 35.2% and severe symptoms in 12.4% of patients. Elevated symptoms of either anxiety (28.3%), depression (2.9%) or both (15.8%) were found and did not differ between adolescents (10-17 years) and young adults (18-25 years). Active disease significantly predicted depressive symptoms (odds ratio (OR): 4.6 [95% confidence interval [CI]: 2.4-8.8], P < 0.001). Female gender (OR: 1.7 [95% CI: 1.1-2.7]), active disease (OR: 1.9 [95% CI: 1.1-3.2]) and a shorter disease duration (OR: 1.3 [95% CI: 0.6-1.0) (all P < 0.025) significantly predicted anxiety and/or depressive symptoms. CONCLUSIONS: Considering the high prevalence of anxiety and depressive symptoms, psychological screening is recommended in young IBD patients. Screening facilitates early recognition and psychological treatment. Female patients and patients with active disease are the most vulnerable.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. van den Brink G, Stapersma L, Vlug LE, et al. Clinical disease activity is associated with anxiety and depressive symptoms in adolescents and young adults with inflammatory bowel disease. Aliment Pharmacol Ther. 2018. PMID: 29897134. doi:10.1111/apt.14832

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。